{"title":"Regulatory Aspects in Using Surrogate Markers in Clinical Trials","authors":"Aloka G Chakravarty","doi":"10.1007/0-387-27080-9_3","DOIUrl":"https://doi.org/10.1007/0-387-27080-9_3","url":null,"abstract":"","PeriodicalId":375789,"journal":{"name":"The Evaluation of Surrogate Endpoints","volume":"57 1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123513173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}